��������

Ted Bird is the Founder and CEO of Bird Medical Group, Inc., a strategic management consultancy established to support emerging and growth-stage MedTech companies in the US. With extensive experience in the MedTech industry, Ted currently serves as Chairman of the Board for Askel Healthcare Ltd, where efforts focus on funding FDA trials for innovative orthopedic solutions. As a strategic advisor for ORTHOSON Ltd, Ted aids in advancing spinal disc degeneration treatments. Ted held significant roles including Chief Strategy Officer at Dymicron, Board Member at Novum Medical, and Chief Commercial Officer at Titan Spine, where notable achievements include leading FDA studies and driving commercialization strategies. Ted's early career includes executive positions at Johnson & Johnson MedTech, contributing to substantial sales growth and educational initiatives in spine technology. Ted's academic credentials include a Bachelor of Arts from Brown University and executive education from Duke University.